BCRX
BioCryst Pharmaceuticals Inc
8.60$
+0.8%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -63.0% | +540.0% | -60.9% | +32.6% | +236.5% | -84.1% | -7.9% | -79.4% | -54.9% | +3,990.4% | +1,046.8% | -20.6% | +31.9% | -14.9% | -69.1% | +33.9% | -34.1% | -21.5% | +254.6% | -45.4% | -4.4% | -18.0% | +136.5% | -63.5% | +782.4% | +72.3% | +22.4% | +36.0% | +94.1% | |
| – | -108.5% | – | – | – | +21.0% | +13.2% | -83.0% | +242.6% | +37.3% | +141.0% | +118.9% | -34.9% | -90.3% | -98.1% | +79,186.0% | -99.8% | -25.8% | +24.5% | +1,454.1% | +42.4% | -36.9% | -72.3% | +770.7% | -59.1% | +333.4% | -9.2% | -29.3% | +167.9% | +52.8% | |
| – | – | +331.3% | -56.5% | +10.5% | +236.5% | -84.1% | -7.9% | -79.4% | -54.9% | +3,990.4% | +1,046.8% | -20.6% | +23.8% | -9.5% | -69.0% | +33.2% | -34.1% | -21.7% | +243.8% | -49.0% | -0.7% | -14.1% | +121.7% | -63.9% | +829.0% | +76.3% | +23.7% | +34.1% | +95.3% | |
| – | – | -12.3% | -17.2% | +24.6% | +36.5% | +18.2% | -25.5% | +63.8% | +25.3% | +99.1% | +99.8% | -22.0% | -1.4% | +14.1% | -31.0% | -9.6% | -17.0% | +21.2% | +40.5% | -16.1% | +9.8% | +26.8% | +26.1% | +14.8% | +69.8% | +21.3% | -14.5% | -19.4% | -4.9% | |
| – | +0.0% | +14.8% | -6.5% | +22.7% | -14.2% | -6.4% | -1.5% | +14.2% | +14.8% | +65.7% | +55.0% | +9.9% | +10.4% | +23.5% | -13.0% | -44.6% | -23.5% | +42.9% | +74.9% | -13.8% | +23.8% | +111.8% | +25.8% | +65.3% | +84.3% | +27.7% | +37.8% | +26.8% | +38.1% | |
| – | +334.4% | -7.2% | -14.0% | +18.4% | +22.8% | +13.5% | -21.8% | +54.1% | +23.7% | +94.6% | +94.6% | -19.1% | +0.1% | +15.4% | -28.4% | -15.8% | -17.7% | +23.6% | +44.8% | -15.8% | +11.9% | +41.4% | +26.0% | +32.4% | +71.6% | +26.0% | +4.3% | +2.4% | +16.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +23.6% | +2.4% | +4.6% | +4.0% | +24.8% | +32.0% | +7.1% | +29.6% | +21.9% | +308.9% | +67.1% | +9.2% | -9.0% | -19.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -1,800.0% | – | – | – | – | – | -3,393,355.7% | – | – | -2,519.3% | – | -182.1% | – | – | -98.7% | -37.6% | +10.8% | +7.8% | +4.1% | +19.6% | +30.9% | -72.7% | +420.9% | +23.1% | -83.6% | +21.3% | -88.7% | +521.6% | +83.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +2,614.3% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.